 |
|
Serum calcification propensity and its association with biochemical parameters and bone mineral density in hemodialysis patients
Hyunsook Kim, Ae Jin Kim, Han Ro, Jae Hyun Chang, Hyun Hee Lee, Wookyung Chung, Ji Yong Jung
Kidney Res Clin Pract. 2023;42(2):262-271. Published online 2022 Oct 25 DOI: https://doi.org/10.23876/j.krcp.22.059
|
|
Citations to this article as recorded by
 The effect of sevelamer on serum calcification propensity in patients with chronic kidney disease: the results of a multicentre, double-blind, placebo-controlled, randomized clinical trial
Maxime Pluquet, Solène M Laville, François Brazier, Pablo Ureña-Torres, Najeh El Esper, Said Kamel, Gabriel Choukroun, Sophie Liabeuf
Clinical Kidney Journal.2025;[Epub] CrossRef Effect of Denosumab on Bone Health, Vascular Calcification, and Health-Related Quality of Life in Hemodialysis Patients with Osteoporosis: A Prospective Observational Study
Hyunsook Kim, Eun Ju Lee, Siyun Woo, Sohee Rho, Ji Yong Jung
Journal of Clinical Medicine.2024; 13(5): 1462. CrossRef The Bone-Vascular Axis: A Key Player in Chronic Kidney Disease Associated Vascular Calcification
Yingjing Shen, Chen Yu
Kidney Diseases.2024; : 1. CrossRef
|